LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Low Cost Portable Genomic Sequencing Platform to Help Labs in Developing Countries Track SARS-CoV-2 Variants

By LabMedica International staff writers
Posted on 02 Sep 2021
Print article
Image: Portable genomics device (Photo courtesy of Michael Bacus)
Image: Portable genomics device (Photo courtesy of Michael Bacus)
An international volunteer team of scientists has brought a portable sequencing platform for SARS-CoV-2 monitoring to developing countries.

Scientists at the Philippine Genome Center Mindanao (Davao, Philippines) and the University of Amsterdam (Amsterdam, Netherlands) have partnered with Accessible Genomics, a group of volunteering scientists from all around the world to implement a low start-up cost genomic sequencing platform for laboratories in developing countries. Genomic data can be used to identify and track variants of the virus, which helps scientists and government officials make better decisions about quarantine measures and vaccine administration. However, not all countries have access to the equipment, chemicals, and know-how to perform enough genomic sequencing to sufficiently track SARS-CoV-2 variants. Genomic sequencing is rare in low-income countries and prevents local governments and hospitals to make better-informed decisions to lower infections and deaths.

A group of students and scientists from the field of portable genomics who have formed Accessible Genomics piloted SARS-CoV-2 sequencing in a representative lab from the Philippines which has complementary skills, facility, and experience on next generation sequencing, using recent advances in portable genomics technology. This partnership will serve as a learning experience for the local centre as it prepares to expand its omics facility and services in the region. Currently, plans are underway to fast-track the expansion of genomic surveillance in the main regions of the country through the Department of Health and Department of Science and Technology, as well as other efforts by both the government and private sectors in the country. The next step of the project is to replicate the initiative in other countries and help labs in other developing countries to get started in variant identification.

“Like many developing countries, genomic sequencing machines in the Philippines were all housed in labs in the capital, Metro Manila. This was because sequencing machines used to cost more than a car and were as large as refrigerators”, said Ineke Knot from the Institute for Biodiversity and Ecosystem Dynamics (IBED) at the University of Amsterdam. “Portable genomic sequencing was made possible in the past few years due to innovations like the MinION sequencer by Oxford Nanopore Technologies. This sequencing machine costs less than an iPhone and is as small as one too.”

Related Links:
Philippine Genome Center Mindanao
University of Amsterdam


Gold Member
Universal Transport Solution
Puritan®UniTranz-RT
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Anti-HHV-6 IgM Assay
anti-HHV-6 IgM ELISA (semiquant.)
New
Toxoplasma Gondii Immunoassay
Toxo IgM AccuBind ELISA Kit

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.